Haisco Pharmaceutical Group Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceutical products and medical equipment. It offers narcotic analgesics, endocrine system, enteral parenteral nutrition, neuropsychiatric, cardiovascular, tumor related, and digestive liver disease drugs. The company was founded in 2000 and is headquartered in Shannan, China.
Fundamental metrics to determine fair value of the stock
Company’s recent performance and margins
Dividend yield, history and sustainability
Financial position and solvency of the company